Advertising & Content Sponsorship Solutions:|info@pharmacmc.com

EMA Personalised Medicines Focus On Patients And Healthcare Professionals Live Broadcast 14th March 2017

Home/Innovation, Pharma CMC, Regulation, Videos/EMA Personalised Medicines Focus On Patients And Healthcare Professionals Live Broadcast 14th March 2017

EMA Personalised Medicines Focus On Patients And Healthcare Professionals Live Broadcast 14th March 2017

EMA Personalised Medicines Focus On Patients And Healthcare Professionals Live Broadcast 14th March 2017

EMA Joint Workshop Broadcast Live: Personalised Medicines

Focus On Patients And Healthcare Professionals – March 15th, 2017

A meeting report will be produced and published on the EMA website

 

This EMA workshop will discuss the role of patients, consumers and healthcare professionals.

How has the concept of personalised medicine evolved globally and in the European Union and what are its regulatory challenges and opportunities?

These are some of the issues the European Medicines Agency (EMA) will be discussing with its Patients’ and Consumers’ Organisations Working Party (PCWP) and its Healthcare Professionals’ Organisations Working Party (HCPWP) at their joint meeting on 14 March 2017 in London.

Morning sessions will be broadcast live on the EMA website, from 8:50 to 13:15.

 

Follow the broadcast by clicking on the ‘multimedia’ tab on the event page on the day of the event.

 

 EMA Workshop Meeting

 

 

Personalised Medicines

Personalised medicine is often seen as the next frontier in patient-centered health care. There is no common definition of the term, but it is often referred to as a medical model for tailoring the right therapeutic strategy for the right person at the right time, on the basis of an individual’s characteristics and genetic makeup.

The workshop aims to explain terminology and concepts relating to personalised medicines. It will also examine how EMA and the European medicines regulatory networkapproach and support the development and evaluation of personalised medicines. Finally, it will look at how patients and healthcare professionals can contribute to this process.

In a closed session taking place in the afternoon of 14 March representatives from patients’, consumers’ and healthcare professionals’ organisations will discuss how they can encourage the translation of scientific advances and biomedical discoveries into genuine improvements in healthcare.

 

 



More details on how to register via the link below.

Register for this webinar

Source Pharma Machinery And Equipment Suppliers By Unit Process

Related Articles

 Join The Discussion

If you want to share your opinion or insights on pharma topics you can join the conversation on LinkedIn, Twitter and other social media channels below using the hashtag #PharmaCMC.


Share Quality Reports, Papers & Articles

To submit your own report, video, white paper or article that adds value for our community of pharmaceutical engineers, procurement managers and key decision makers please contact us via email.

Newsletters | Resources | Suppliers  GET MONTHLY UPDATES

Your Name (required)

Your Email (required)

2017-05-23T17:47:59+00:00

About the Author:

The PharmaCMC Journal editorial team is made up of a panel of experienced pharmaceutical engineers, scientists, procurement managers and content specialists. We focus on valuable content that solves the everyday challenges facing pharma professionals interested in sourcing pharmaceutical machines and equipment from peer recommended suppliers who meet the modern "Quality by Design" QbD and "Risk Based Design" requirements and specifications.